Gender-based analysis of esophageal cancer patients undergoing preoperative chemoradiation: Differences in presentation and therapy outcome

Diseases of the Esophagus

Volumn 19, Issue 3, 2006, Pages 152-157

  Rohatgi, P R ^a   Correa, A M ^a   Swisher, S G ^a   Wu, T T ^a   Liao, Z ^a   Komaki, R ^a   Walsh, G L ^a   Vaporciyan, A A ^a   Lee, J H ^a   Rice, D C ^a   Roth, J A ^a   Ajani, J A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Esophageal cancer; Gender; Outcome; Preoperative chemoradiation

Indexed keywords

CISPLATIN; DOCETAXEL; FLUOROURACIL; IRINOTECAN; PACLITAXEL;

ADULT; ADVANCED CANCER; ARTICLE; CANCER CLASSIFICATION; CANCER LOCALIZATION; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; ESOPHAGUS CANCER; ESOPHAGUS CARCINOMA; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; OBSERVATIONAL STUDY; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; SURVIVAL TIME; TREATMENT FAILURE; TREATMENT OUTCOME;

CHEMOTHERAPY, ADJUVANT; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SEX FACTORS; TREATMENT OUTCOME;

EID: 33646774647     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2006.00557.x     Document Type: Article

References (14)

1. www.cancer.org/ (Accessed June 2005).
2. Enzinger P C, Mayer R J. Esophageal cancer. N Engl J Med 2003; 349: 2241-52.
3. Medical Research Council Oesophageal Cancer Working Group. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: A randomixed controlled trial. Lancet 2002; 359: 1727-33.
4. Orringer M B, Marshall B, Iannettoni M D. Transhiatal esophagectomy. clinical experience and refinements. Ann Surg 1999; 230: 392-400.
5. Altorki N, Kent M, Ferrara C et al. Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus. Ann Surg 2002; 236: 177-83.
6. Akiyama H, Tsurumara M, Udagawa H et al. Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg 1994; 220: 364-72.
7. Lerut T, De Leyn P, Coosemans W et al. Surgical strategies in esophageal carcinoma with emphasis on radical lymphadenectomy. Ann Surg 1992; 216: 583-90.
8. Forastiere A A, Orringer M B, Perez-Tamayo C et al. Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus: Final report. J Clin Oncol 1993; 11: 1118-23.
9. Keller S M, Ryan L M, Coia L R et al. High Dose Chemoradiotherapy followed by esophagectomy for adenocarcinoma of the esophagus and gastroesophageal junction. Cancer 1998; 83: 1908-16.
10. Jiao X, Krasna M J, Sonett J et al. Pretreatment surgical lymph node staging predicts results of trimodality therapy in esophageal cancer. Eur J Cardiothorac Surg 2001; 19: 880-6.
11. Szumilo J, Chibowski D, Browski A. Assessment of the predictive value of clinical and histopathological factors as well as the immunoexpression of p53 and bcl-2 proteins in response to preoperative chemotherapy for esophageal squamous cell carcinoma. Dis Esophagus 2000; 13: 191-7.
12. Posner M C, Gooding W E, Landreneau R J. Preoperative chemoradiotherapy for carcinoma of the esophagus and gastroesophageal junction. Cancer J Sci Am Aug 1993; 4: 237-46.
13. Denham J W, Steigler A, Kilmurray J et al. Relapse patterns after chemo-radiation for carcinoma of the oesophagus. Clin Oncol (R Coll Radiol) 2003; 15: 98-108.
14. Rohatgi P R, Swisher S G, Correa A M et al. Prediction of Pathologic Complete Response After Preoperative Chemoradiotherapy in Carcinoma of the Esophagus and Outcome After Pathologic Complete Response. Cancer (In press, 2005).